Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 35129294

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2022 Apr
First author
Haduong JH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Haduong JH
      type
      Author
    2. name
      Heske CM
      type
      Author
    3. name
      Allen-Rhoades W
      type
      Author
    4. name
      Xue W
      type
      Author
    5. name
      Teot LA
      type
      Author
    6. name
      Rodeberg DA
      type
      Author
    7. name
      Donaldson SS
      type
      Author
    8. name
      Weiss A
      type
      Author
    9. name
      Hawkins DS
      type
      Author
    10. name
      Venkatramani R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Haduong JH
      type
      Author
    2. name
      Heske CM
      type
      Author
    3. name
      Allen-Rhoades W
      type
      Author
    4. name
      Xue W
      type
      Author
    5. name
      Teot LA
      type
      Author
    6. name
      Rodeberg DA
      type
      Author
    7. name
      Donaldson SS
      type
      Author
    8. name
      Weiss A
      type
      Author
    9. name
      Hawkins DS
      type
      Author
    10. name
      Venkatramani R
      type
      Author
    bibliography ids
    1. nci-bib-193f84052ca310db40f4beda
    book metadata
    content sha256
    9dd5b8ef4ceafb8d0cec15095f58b0403f0313a8c1ba8836156b5f8202b39c68
    document type
    citation
    dois
    1. 10.1002/pbc.29511
    electronic publication date
    display
    2022 Feb 7
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35129294
    immutable id
    pubmed:35129294@9dd5b8ef4ceafb8d0cec15095f58b0403f0313a8c1ba8836156b5f8202b39c68
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    4
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e29511
    volume
    69
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35129294
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      b55b2f9aae032e0422fa6b9e19ee9b74f429f5eacc238626e91cc87386806e82
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Apr
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Review
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35129294/
      title
      An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.

      Preserved source evidence · Independent clinical review pending · Not medical advice